Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
The Food and Drug Administration (FDA) has granted clearance to the Acuvue Oasys Contact Lenses with Transitions Light Intelligent Technology (Johnson & Johnson), the first contact lens with light adaptive technology for daily use in patients with myopia or hyperopia, and in patients with certain degrees of astigmatism.
The new lenses contain a photochromic additive that automatically darkens the lens when exposed to bright light. The slightly darkened lenses then return to a regular tint when exposed to normal or darker conditions. The lenses are meant for daily wear for up to 14 days and should not be used as a substitute for UV protective eyewear.
The FDA’s decision was based on scientific data from a clinical study (N=24) that assessed both day and nighttime driving ability while wearing the contact lenses. The findings showed no concerns with driving performance or vision while wearing the lenses.
“This contact lens is the first of its kind to incorporate the same technology that is used in eyeglasses that automatically darken in the sun,” said Malvina Eydelman, director of the Division of Ophthalmic, and Ear, Nose and Throat Devices at the FDA’s Center for Devices and Radiological Health.
The lenses are expected to be available in the first half of 2019.
For more information visit FDA.gov.
